Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,643 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lentiviral vectors for inducible, transactivator-free advanced therapy medicinal products: Application to CAR-T cells.
Tristán-Manzano M, Maldonado-Pérez N, Justicia-Lirio P, Cortijo-Gutierréz M, Tristán-Ramos P, Blanco-Benítez C, Pavlovic K, Aguilar-González A, Muñoz P, Molina-Estevez FJ, Griesche V, Marchal JA, Heras SR, Benabdellah K, Martin F. Tristán-Manzano M, et al. Among authors: munoz p. Mol Ther Nucleic Acids. 2023 Mar 28;32:322-339. doi: 10.1016/j.omtn.2023.03.018. eCollection 2023 Jun 13. Mol Ther Nucleic Acids. 2023. PMID: 37125150 Free PMC article.
Physiological lentiviral vectors for the generation of improved CAR-T cells.
Tristán-Manzano M, Maldonado-Pérez N, Justicia-Lirio P, Muñoz P, Cortijo-Gutiérrez M, Pavlovic K, Jiménez-Moreno R, Nogueras S, Carmona MD, Sánchez-Hernández S, Aguilar-González A, Castella M, Juan M, Marañón C, Marchal JA, Benabdellah K, Herrera C, Martin F. Tristán-Manzano M, et al. Among authors: munoz p. Mol Ther Oncolytics. 2022 May 18;25:335-349. doi: 10.1016/j.omto.2022.05.003. eCollection 2022 Jun 16. Mol Ther Oncolytics. 2022. PMID: 35694446 Free PMC article.
Lent-On-Plus Lentiviral vectors for conditional expression in human stem cells.
Benabdellah K, Muñoz P, Cobo M, Gutierrez-Guerrero A, Sánchez-Hernández S, Garcia-Perez A, Anderson P, Carrillo-Gálvez AB, Toscano MG, Martin F. Benabdellah K, et al. Among authors: munoz p. Sci Rep. 2016 Nov 17;6:37289. doi: 10.1038/srep37289. Sci Rep. 2016. PMID: 27853296 Free PMC article.
Erratum: Physiological lentiviral vectors for the generation of improved CAR-T cells.
Tristán-Manzano M, Maldonado-Pérez N, Justicia-Lirio P, Muñoz P, Cortijo-Gutiérrez M, Pavlovic K, Jiménez-Moreno R, Nogueras S, Carmona MD, Sánchez-Hernández S, Aguilar-González A, Castella M, Juan M, Marañón C, Marchal JA, Benabdellah K, Herrera C, Martin F. Tristán-Manzano M, et al. Among authors: munoz p. Mol Ther Oncolytics. 2022 Jul 21;26:245. doi: 10.1016/j.omto.2022.07.005. eCollection 2022 Sep 15. Mol Ther Oncolytics. 2022. PMID: 35919458 Free PMC article.
Efficacy and safety of universal (TCRKO) ARI-0001 CAR-T cells for the treatment of B-cell lymphoma.
Maldonado-Pérez N, Tristán-Manzano M, Justicia-Lirio P, Martínez-Planes E, Muñoz P, Pavlovic K, Cortijo-Gutiérrez M, Blanco-Benítez C, Castella M, Juan M, Wenes M, Romero P, Molina-Estévez FJ, Marañón C, Herrera C, Benabdellah K, Martin F. Maldonado-Pérez N, et al. Among authors: munoz p. Front Immunol. 2022 Oct 6;13:1011858. doi: 10.3389/fimmu.2022.1011858. eCollection 2022. Front Immunol. 2022. PMID: 36275777 Free PMC article.
Isogenic GAA-KO Murine Muscle Cell Lines Mimicking Severe Pompe Mutations as Preclinical Models for the Screening of Potential Gene Therapy Strategies.
Aguilar-González A, González-Correa JE, Barriocanal-Casado E, Ramos-Hernández I, Lerma-Juárez MA, Greco S, Rodríguez-Sevilla JJ, Molina-Estévez FJ, Montalvo-Romeral V, Ronzitti G, Sánchez-Martín RM, Martín F, Muñoz P. Aguilar-González A, et al. Among authors: munoz p. Int J Mol Sci. 2022 Jun 4;23(11):6298. doi: 10.3390/ijms23116298. Int J Mol Sci. 2022. PMID: 35682977 Free PMC article.
1,643 results